BCM
GMED icon

Bares Capital Management’s Globus Medical GMED Stock Holding History

Bares Capital Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$29.8M Buy
+521,129
New +$30M 2.75% 10

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Bares Capital Management's GMED Position: Q3 2025 in Review

Bares Capital Management opened a new position in Globus Medical (GMED) in Q3 2025: 521,129 shares worth $29.8M. The stake represents 2.75% of the portfolio and ranks #10 among its holdings.

489 funds tracked by Wall St. Rank hold GMED as of Q3 2025.

  • Bares Capital Management held 521,129 shares of Globus Medical worth $29.8M as of Q3 2025.
  • Globus Medical was a new Bares Capital Management position in Q3 2025.
  • Globus Medical made up 2.75% of Bares Capital Management's portfolio in Q3 2025, its #10 holding.
  • 489 funds tracked by Wall St. Rank held Globus Medical as of Q3 2025.

Based on Bares Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.